Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kirsi Taimen"'
Autor:
Saara Huoponen, Kalle J Aaltonen, Jaana Viikinkoski, Jarno Rutanen, Heikki Relas, Kirsi Taimen, Kari Puolakka, Dan Nordström, Marja Blom
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0220142 (2019)
ObjectivesThe objective of this study was to evaluate the cost-effectiveness of abatacept, tocilizumab, and tumor necrosis factor (TNF) inhibitors as compared with rituximab in Finnish rheumatoid arthritis patients, who have previously been treated w
Externí odkaz:
https://doaj.org/article/a9ece47ac08041dbae4ab1ee1bbea2da
Autor:
Anna-Mari Hokkanen, Kalle Aaltonen, Heikki Relas, Jarno Rutanen, Aulikki Kononoff, Kirsi Taimen, Markku Kauppi, Kari Puolakka, Nina Trokovic, Dan Nordström
Publikováno v:
Rheumatology Advances in Practice.
Objectives To investigate the effect of tumor necrosis factor inhibitor (TNFi) initiation on working ability and health care resource utilization among axial spondyloarthritis patients in a real-life setting. Methods Patients with a clinical diagnosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baa3a3b36178082cfe614625096c52ef
https://doi.org/10.1093/rap/rkad050
https://doi.org/10.1093/rap/rkad050
Publikováno v:
Rheumatology and Therapy
Introduction The diagnosis of systemic vasculitis is a challenge because of the heterogeneity of clinical manifestations. The aim of this study is to analyze the diagnostic delay in systemic vasculitis, the total costs during the first year of care,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::541fa2fc310659c3bec7040948cc91db
http://europepmc.org/articles/PMC7991036
http://europepmc.org/articles/PMC7991036
Autor:
Laura Pirilä, Juhani Knuuti, Mikko Koivumäki, Petteri Lankinen, Vesa Oikonen, Xiang-Guo Li, Sirpa Jalkanen, Kristiina Santalahti, Riikka Viitanen, Tuula Tolvanen, Ia Kohonen, Anne Roivainen, Pirjo Nuutila, Helena E. Virtanen, Antti Saraste, Markku Mali, Sami Suilamo, Anu Autio, Olli Moisio, Ilpo Koskivirta, Kirsi Taimen
Publikováno v:
Journal of Nuclear Medicine. 62:577-583
Sialic acid-binding immunoglubulin-like lectin 9 (Siglec-9) is a ligand of vascular adhesion protein 1 (VAP-1). A gallium 68-labeled peptide of Siglec-9, 68Ga-DOTA-Siglec-9, holds promise as a novel PET tracer for imaging of inflammation. This first-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ccd5aa8ab9f55ea12cf625403880b19
https://doi.org/10.2967/jnumed.120.250696
https://doi.org/10.2967/jnumed.120.250696
Autor:
Riikka, Viitanen, Olli, Moisio, Petteri, Lankinen, Xiang-Guo, Li, Mikko, Koivumäki, Sami, Suilamo, Tuula, Tolvanen, Kirsi, Taimen, Markku, Mali, Ia, Kohonen, Ilpo, Koskivirta, Vesa, Oikonen, Helena, Virtanen, Kristiina, Santalahti, Anu, Autio, Antti, Saraste, Laura, Pirilä, Pirjo, Nuutila, Juhani, Knuuti, Sirpa, Jalkanen, Anne, Roivainen
Publikováno v:
Journal of Nuclear Medicine
Visual Abstract
Sialic acid–binding immunoglubulinlike lectin 9 (Siglec-9) is a ligand of vascular adhesion protein 1. A 68Ga-labeled peptide of Siglec-9, 68Ga-DOTA-Siglec-9, holds promise as a novel PET tracer for imaging of inflammation. Thi
Sialic acid–binding immunoglubulinlike lectin 9 (Siglec-9) is a ligand of vascular adhesion protein 1. A 68Ga-labeled peptide of Siglec-9, 68Ga-DOTA-Siglec-9, holds promise as a novel PET tracer for imaging of inflammation. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0df1e850fa18a8ee8388a9d39836ad0
https://pubmed.ncbi.nlm.nih.gov/32817143
https://pubmed.ncbi.nlm.nih.gov/32817143
Autor:
Kirsi Taimen, Laura Pirilä, Ia Kohonen, Heikki Relas, Samu Heino, Riikka Huovinen, Arno Hänninen
Publikováno v:
Rheumatology Advances in Practice
Objective Patients receiving chemotherapy are prone to neutropoenic infections, presenting with non-specific symptoms such as a high fever and elevated inflammatory parameters. Large-vessel vasculitis (LVV) may have a similar clinical presentation an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b208a4c31f8cc8b34fec91f9b7fc67c1
https://doi.org/10.1093/rap/rkaa004
https://doi.org/10.1093/rap/rkaa004
Autor:
Markku Kauppi, Markku Mali, J Asikainen, L Kuusalo, M Puurtinen-Vilkki, P. Isomäki, Kirsi Taimen, J Paltta, Laura Pirilä, Kari Laiho, T Rannio, T. Yli-Kerttula, Hannu Kautiainen, Tuulikki Sokka, T. Uotila, Pekka Hannonen, S. Nyrhinen, Kalle Aaltonen, S. Kortelainen, P Ekman, Heidi Mäkinen
Publikováno v:
Scandinavian Journal of Rheumatology. 46:425-431
To assess what proportion of patients with disease-modifying anti-rheumatic drug (DMARD)-naïve early rheumatoid arthritis (ERA) reach 28-joint Disease Activity Score (DAS28) remission over 1 year, and remission variability across clinics in Finland.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9deb535232344ae66086d53ee36f4f3
https://doi.org/10.1080/03009742.2016.1266029
https://doi.org/10.1080/03009742.2016.1266029
Autor:
Dan Nordström, Heikki Relas, Kirsi Taimen, Marja Blom, Jarno Rutanen, Kalle Aaltonen, Kari Puolakka, Saara Huoponen, Jaana Viikinkoski
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 7, p e0220142 (2019)
PLoS ONE, Vol 14, Iss 7, p e0220142 (2019)
ObjectivesThe objective of this study was to evaluate the cost-effectiveness of abatacept, tocilizumab, and tumor necrosis factor (TNF) inhibitors as compared with rituximab in Finnish rheumatoid arthritis patients, who have previously been treated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93356ff68943eb8a322e4a3b54b23023
http://europepmc.org/articles/PMC6656352
http://europepmc.org/articles/PMC6656352
Autor:
Kirsi Taimen, Laura Pirilä, Ia Kohonen, Riikka Huovinen, Arno Hänninen, Samu Heino, Heikki Relas
Publikováno v:
Poster Presentations.
Background Large vessel vasculitis (LVV) and neutropenic infection in patients receiving chemotherapy present similar clinical symptoms with fever and high inflammation parameters. Infection is more frequent but LVV should be kept in mind as differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96e11935218e6799591626abcc12c59e
https://doi.org/10.1136/annrheumdis-2019-eular.5009
https://doi.org/10.1136/annrheumdis-2019-eular.5009
Autor:
Pirjo Nuutila, Kirsi Taimen, Laura Pirilä, Antti Palomäki, Ulla Hohenthal, Sami Kajander, Anne Roivainen, Marko Seppänen, Soile Pauliina Salomäki, Jukka Kemppainen, Markku Mali
Publikováno v:
Contrast Media & Molecular Imaging, Vol 2019 (2019)
Contrast Media & Molecular Imaging
Contrast Media & Molecular Imaging
18F-Fluorodeoxyglucose positron-emission tomography (18F-FDG-PET) with computed tomography (CT) is effective for diagnosing large vessel vasculitis, but its usefulness in accurately diagnosing suspected, unselected vasculitis remains unknown. We eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::615cf1aa8e8c67eec70cee219d62ca65